Knowledge capture within the biopharmaceutical clinical trials environment

Emerald - 2008
MartinGrossman1, StephenBates2
1Bridgewater State College, Bridgewater, Massachusetts, USA
2Perceptive Informatics, Inc., Waltham, Massachusetts, USA

Tóm tắt

PurposeThe purpose of this paper is to provide an overview of knowledge capture in the biopharmaceutical industry, focusing primarily on the transition from paper‐based to electronic data capture (EDC) systems.Design/methodology/approachThe paper draws on biopharmaceutical industry literature and data from example clinical studies to describe the issues involved in transitioning to EDC in the clinical trials environment.FindingsWhile electronic data capture systems provide greater efficiencies along the clinical trial supply chain, the industry is still far from achieving wide scale utilization of such technologies. The barriers to successful implementation are multifaceted, involving not only the information technology itself, but also user acceptance issues, lack of interoperability standards, and regulatory compliance. Major shifts in organizational culture and a unified effort within the industry will be necessary in order to derive full benefits from electronic capture systems in the future.Research limitations/implicationsThis study was limited in that case data from only one company was used to supplement the literature review. Further research is warranted to better understand the factors that facilitate adoption of electronic knowledge capture systems in the biopharmaceutical industry.Originality/valueWhile the need for knowledge management in the healthcare industry is indisputable, there has been remarkably slow progress in this area, and a dearth of research exploring implementation issues. The value of this type of inquiry is profound as it will help us better understand the issues in implementation and adoption, and ultimately to deliver more effective and safe drugs to the public in a more efficient manner.

Từ khóa


Tài liệu tham khảo

Bart, T. (2003), “Comparison of electronic data capture with paper data collection: is there really an advantage?”, Business Briefing Pharmatech, pp. 1‐4.

Beyster, M.A., Hardison, D.H. and Lubin, G.M. (2005), “Improving clinical trials by implementing information technology: where will you be in three years?”, Science Applications International Corporation, San Diego, CA, available at: www.saic.com/life‐sciences/pdfs/mcv.pdf.

Bushnell, D.M., Reilly, M.C., Galani, C., Martin, M.L., Ricci, J., Patrick, D.L. and McBurney, C.R. (2006), “Validation of electronic data capture of the irritable bowel syndrome: quality of life measure, the work productivity and activity impairment questionnaire of irritable bowel syndrome and EuroQol”, Value in Health, Vol. 9 No. 2, pp. 98‐105.

Carel, R. and Pollard, J. (2003), “Knowledge management in drug discovery R&D”, 3rd Millennium, Inc., Waltham, MA, available at: www.3rdmill.com/resources/3rd_Millennium_KM_in_Pharma_RD.pdf.

Dalkir, K. (2005), Knowledge Management in Theory and Practice, Elsevier Butterworth‐Heinemann, Burlington, MA.

Ericcson, F. and Avdic, A. (2003), “Knowledge management systems acceptance”, in Coakes, E. (Ed.), Knowledge Management: Current Issues and Challenges, IRM Press, Hershey, PA.

Health Industry Insights (2007), “Electronic data capture (EDC) poised to disrupt life sciences industry”, May, available at: www.healthindustry‐insights.com/HII/getdoc.jsp?containerId=prUS20671907.

Hodgson, J. (2001), “The headache of knowledge management”, Nature Biotechnology, Vol. 19 No. 6, pp. 44‐6, available at: www.pharmaknowledge.com/Nature%20Biotechnology%20article.htm.

Hyde, A.W. (1998), “The changing face of electronic data capture: from remote data entry to direct data capture”, Drug Information Journal, Vol. 32, pp. 1089‐92.

IMS (2007), “IMS Health reports global pharmaceutical market grew 7.0 percent in 2006, to $643 billion”, 20 March, available at: www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_80560241,00.html.

Kim, K. (2005), “Clinical data standards in healthcare”, iHealth Reports, California HealthCare Foundation, Oakland, CA, July, available at: www.chcf.org/documents/ihealth/ClinicalDataStandardsInHealthCare.pdf.

Kush, R. (2006), “Electronic data capture: pros and cons”, BioExecutive International, Vol. 2 No. 6, pp. S48‐S52.

Lauritsen, K., Degl'Innocenti, A., Lene, H., Jørgen, P., Lytje, M.F., Clemmensen‐Rotne, K. and Wiklund, I. (2004), “Symptom recording in a randomised clinical trial: paper diaries vs electronic or telephone data capture”, Controlled Clinical Trials, Vol. 25 No. 6, pp. 585‐97.

Leavitt, P.M. (2002), “The role of knowledge management in new drug development”, American Productivity & Quality Center, available at: www.providersedge.com/docs/km_articles/Role_of_KM_in_New_Drug_Development.pdf.

Malhotra, Y. (2003), Measuring Knowledge Assets of a Nation: Knowledge Systems for Development, Report of the Ad Hoc Group Meeting on Knowledge Systems for Development, , United Nations Headquarters, NYC, NY, 4‐5 September, pp. 68‐126.

Marks, R.G. (2004), “Validating electronic source data in clinical trials”, Controlled Clinical Trials, Vol. 25 No. 5, pp. 437‐46.

Outcome Sciences (2004), “Health information portability and accountability act (HIPAA): implications for data capture with special reference to web‐based electronic data capture”, available at: www.outcome.com/new_home/images/HIPAA_EDC_Outcome_Sciences.pdf.

Pratt, T. (2007), “EDC: caught in a trap”, Applied Clinical Trials, June, pp. 26‐8.

Rao, M. (2005), “Overview: the social life of KM tools”, in Rao, M. (Ed.), Knowledge Management Tools and Techniques: Practitioners and Experts Evaluate KM Solutions, Elsevier Butterworth‐Heinemann, Oxford.

Sahoo, U. and Bhatt, A. (2003), “Electronic data capture (EDC): a new mantra for clinical trials”, Quality Assurance, Vol. 10, pp. 117‐21.

Sawhney, G., Chandler, B., Williams, K. and Chica, S. (2006), “The role of independent review in oncology trials”, Applied Clinical Trials, May, available at: http://actmagazine.findpharma.com/appliedclinicaltrials/Clinical+Trials/The‐Role‐of‐Independent‐Review‐in‐Oncology‐Trials/ArticleStandard/Article/detail/324333.

Schaltenbrand, N. (2007), “Large‐scale electronic data capture: when size is not the only issue”, Touch Briefings, London, available at: www.touchbriefings.com/pdf/2743/schaltenbrand.pdf.

Sung, N., Crowley, W.F., Genel, M., Salber, P., Sandy, L., Sherwood, L.M., Johnson, S.B., Catnese, V., Tilson, H., Getz, K., Larson, E.L., Scheinberg, D., Reece, E.A., Slavking, H., Dobs, A., Grebb, J., Martinez, R.A., Korn, A. and Rimoin, D. (2003), “Central challenges facing the national clinical research enterprise”, The Journal of the American Medical Association, Vol. 289 No. 10, pp. 1278‐87.

Tyson, G. and Dietlin, T. (2006), “Realizing the promise of electronic data capture: a practical guide”, available at: www.campbellalliance.com/articles/Realizing_the_Promise_of_Clinical_EDC_A_Practical_Guide.pdf.

Vermeiren, K. (2007), “EDC and CDISC, the perfect combination for successful submission”, available at: www.sgs.com/lss_edc_article_ict_sgs_120707_bis.pdf.

Welker, J.A. (2007), “Implementation of electronic data capture systems: barriers and solutions”, Contemporary Clinical Trials, Vol. 28, pp. 329‐36.

eClinical Forum and PhRMA EDC/eSource Taskforce (2006), “The future vision of electronic health records as ESource for clinical research”, available at: www.eclinicalforum.com/content/Knowledge/Articles/Future%20EHR‐CR%20Environment%20Version%201.pdf.